PD Dr. Katja Kobow was awarded with a new research grant (2024-2027)
TOPIC: transgenerational effects of early-life exposure to anti-seizure drugs
We are happy to announce that Katja Kobow, together with Christophe Bernard (Institut de Neurosciences des Systèmes, Aix-Marseille Université, France), will be funded for 3 years by the French Institute for Public Health Research (IReSP) to investigate transgenerational effects of early-life exposure to anti-seizure drugs like Valproate (VPA).
